Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...

NEW YORK CITY (PIX11) — Wait times to go through TSA security at the airport continue to increase across the country as the partial government shutdown drags on. Video taken by PIX11 News in LaGuardia ...

A trio of companies have announced the cancellation of contracts to deliver work on the Trojena ski resort and The Line city as the Neom project in Saudi Arabia stalls. Steel company Eversendai ...

President Lee Jae Myung is pushing to exclude officials who own multiple homes from participating in housing policymaking, with analysts backing the move on credibility grounds while underscoring the ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. At a rally in February, the mayor of ...

IT white papers, webcasts, case studies, and much more - all free to registered TechRepublic members. As someone who has worked closely with small and mid-sized businesses, I see the same challenge ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...

Kesimpta is a prescription medication used to treat clinically isolated syndrome (CIS) and relapsing forms of multiple sclerosis (MS). Kesimpta comes as a solution inside single-dose prefilled ...

The investment seeks long-term total return. The fund will seek to achieve its investment objective by investing principally in a portfolio of residential and commercial mortgage-backed securities and ...

It’s official: There will be no revived effort to ban the Tush Push at next week’s NFL annual meeting in Arizona. As expected, the league’s competition committee released Tuesday its set of formal ...